Related Experiment Video
Updated: Jun 6, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Inflammatory bowel disease in India--changing paradigms
1Gastroenterology Unit, Department of Medicine, B.R. Singh Hospital and Centre for Medical Education and Research, Eastern Railway, Sealdah, Kolkata 700014 West Bengal, India. gautam1910@yahoo.com
Inflammatory bowel disease is increasing in India, with ulcerative colitis now presenting more severely. Crohn's disease in this region often involves the small intestine and responds well to aminosalicylates.
Area of Science:
- Gastroenterology
- Internal Medicine
- Epidemiology
Background:
- Inflammatory bowel disease (IBD) is a growing health concern in Asia, particularly India.
- Limited clinical data and temporal trend information exist for IBD in eastern India.
Purpose of the Study:
- To analyze the clinical characteristics and temporal trends of inflammatory bowel disease in eastern India.
- To compare current IBD patient data with historical data to identify significant changes.
Main Methods:
- Retrieved existing Indian IBD data from PubMed.
- Collected prospective clinical data from 50 IBD patients (40 ulcerative colitis, 10 Crohn's disease) from 2003-2009.
- Analyzed demography, symptoms, disease course, complications, and treatment outcomes using descriptive and analytical statistics.
Main Results:
- Ulcerative colitis patients presented with severe pancolitis, contrasting with milder earlier presentations.
- 27.5% of ulcerative colitis patients developed pseudopolyposis, and 10% developed colon cancer with disease duration >10 years.
- Crohn's disease patients typically had mild small-gut involvement, responsive to aminosalicylates; lower GI bleed was a common presentation.
Conclusions:
- Ulcerative colitis in India is increasingly presenting with greater severity and extent.
- Rapid development of colonic pseudopolyposis is a notable observation in ulcerative colitis patients.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

